- Home
- NRIX vs COHU Comparison
NRIX vs COHU Comparison
Compare NRIX & COHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIX
- COHU
- Stock Information
- Founded
- NRIX 2009
- COHU 1947
- Country
- NRIX United States
- COHU United States
- Employees
- NRIX N/A
- COHU N/A
- Industry
- NRIX Biotechnology: Pharmaceutical Preparations
- COHU Electrical Products
- Sector
- NRIX Health Care
- COHU Industrials
- Exchange
- NRIX Nasdaq
- COHU Nasdaq
- Market Cap
- NRIX 908.0M
- COHU 846.8M
- IPO Year
- NRIX 2020
- COHU N/A
- Fundamental
- Price
- NRIX $11.64
- COHU $19.79
- Analyst Decision
- NRIX Strong Buy
- COHU Buy
- Analyst Count
- NRIX 16
- COHU 7
- Target Price
- NRIX $30.44
- COHU $29.50
- AVG Volume (30 Days)
- NRIX 857.7K
- COHU 407.6K
- Earning Date
- NRIX 07-10-2025
- COHU 07-30-2025
- Dividend Yield
- NRIX N/A
- COHU N/A
- EPS Growth
- NRIX N/A
- COHU N/A
- EPS
- NRIX N/A
- COHU N/A
- Revenue
- NRIX $56,417,000.00
- COHU $390,962,000.00
- Revenue This Year
- NRIX $16.69
- COHU $10.84
- Revenue Next Year
- NRIX N/A
- COHU $14.84
- P/E Ratio
- NRIX N/A
- COHU N/A
- Revenue Growth
- NRIX N/A
- COHU N/A
- 52 Week Low
- NRIX $8.18
- COHU $12.57
- 52 Week High
- NRIX $29.56
- COHU $36.60
- Technical
- Relative Strength Index (RSI)
- NRIX 54.44
- COHU 64.15
- Support Level
- NRIX $11.17
- COHU $17.71
- Resistance Level
- NRIX $11.99
- COHU $19.83
- Average True Range (ATR)
- NRIX 0.58
- COHU 0.60
- MACD
- NRIX -0.07
- COHU 0.07
- Stochastic Oscillator
- NRIX 37.50
- COHU 93.87
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.
About COHU Cohu Inc.
Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).